Literature DB >> 15240672

FTY720-enhanced T cell homing is dependent on CCR2, CCR5, CCR7, and CXCR4: evidence for distinct chemokine compartments.

Adam C Yopp1, Shuang Fu, Shaun M Honig, Gwendalyn J Randolph, Yaozhong Ding, Nancy R Krieger, Jonathan S Bromberg.   

Abstract

FTY720 stimulates CCR7-driven T cell homing to peripheral lymph nodes (LN) by direct activation of sphingosine 1-phosphate receptors, along with the participation of multidrug transporters, 5-lipoxygenase, and G protein-coupled receptors for chemokines. In this study, we demonstrate that FTY720 also directly stimulates in vitro T cell chemotaxis to CCR2-CCL2, but not to a variety of other chemokines, including CCR5-CCL3/4/5 and CXCR4-CXCL12. FTY720 influences CCR2-CCL2-driven migration through activation of the multidrug transporters, Abcb1 and Abcc1, and through 5-lipoxygenase activity. In vivo administration of FTY720 induces chemokine-dependent migration of T cells in the thymus, peripheral blood, LN, and spleen. The CCR7 and CCR2 chemokine ligands are required for both T cell sequestration in LN and thymic T cell egress following FTY720 administration. Furthermore, FTY720 administration uncovers a requirement for CXCR4 ligands for LN homing, but not for thymic egress, and CCR5 for thymic egress, but not LN homing. FTY720-driven splenic and peripheral blood T cell egress are both independent of CCR2, CCR5, CCR7, or CXCR4. These results indicate that FTY720- and sphingosine 1-phosphate receptor-stimulated T cell migration are dependent on the restricted usage of chemokine receptor-ligand pairs within discrete anatomic compartments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240672     DOI: 10.4049/jimmunol.173.2.855

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.

Authors:  Xiangfeng Zeng; Tong Wang; Cairong Zhu; Yanxia Ye; Bing Song; Xinqiang Lai; Yaoying Zeng
Journal:  Inflamm Res       Date:  2012-03-10       Impact factor: 4.575

Review 2.  Immunotherapy for De Novo renal transplantation: what's in the pipeline?

Authors:  Helio Tedesco Silva; Paula Pinheiro Machado; Claudia Rosso Felipe; Jose Osmar Medina Pestana
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.

Authors:  Danielle N Kroetz; George S Deepe
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

4.  The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.

Authors:  Cornelia Halin; M Lucila Scimone; Roberto Bonasio; Jean-Marc Gauguet; Thorsten R Mempel; Elizabeth Quackenbush; Richard L Proia; Suzanne Mandala; Ulrich H von Andrian
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

5.  A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Authors:  C A Huppé; P Blais Lecours; A Lechasseur; D R Gendron; A M Lemay; E Y Bissonnette; M R Blanchet; C Duchaine; M C Morissette; H Rosen; D Marsolais
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

Review 6.  Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.

Authors:  Ralf Gold
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

7.  Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.

Authors:  K Seno; M Yasunaga; H Kajiya; K Izaki-Hagio; H Morita; M Yoneda; T Hirofuji; J Ohno
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

Review 8.  The alliance of sphingosine-1-phosphate and its receptors in immunity.

Authors:  Juan Rivera; Richard L Proia; Ana Olivera
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

9.  Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.

Authors:  Bradley K Wacker; Jennifer L Perfater; Jeffrey M Gidday
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

Review 10.  Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.

Authors:  Jerold Chun; Hans-Peter Hartung
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.